Centre For Local Research into Public Space (CELOS)

See also Site Map

Citizen-Z Cavan Young's 2004 film about the zamboni crisis





Follow Your Nose to Herd Immunity (WSJ Aug.17, 2021)


Michael Segal

The Centers for Disease Control and Prevention’s latest Covid guidelines have many Americans confused. Vaccinated people are supposed to resume wearing masks, lest they contract and spread the virus.

Yet unvaccinated people are still strongly urged to get the shots, which are said to be highly effective. How can both these claims be true?

The answer is that there’s more than one kind of immunity. Internal immunity protects the inside of the body, including the lungs. This occurs by release of antibodies of the Immunoglobulin G type, or IgG, into the blood and production of T-cells. Vaccines injected into our muscles are highly effective at stimulating internal immunity. This largely protects vaccinated people from being overwhelmed by the coronavirus, unless they have an immunodeficiency or are exposed to an unusually large amount of the virus. Vaccination will dramatically reduce your likelihood of serious illness or death if you’re exposed to SARS-CoV-2.

In contrast, mucosal immunity provides the first line of defense by protecting the nose and mouth, and by doing so also reduces spread to others. The mucous membranes secrete a particular form of antibodies of the Immunoglobulin A type, o r IgA. But vaccines injected into our muscles—including all the approved inoculations against Covid—are largely ineffective at stimulating the secretion of IgA into our noses that occurs after actual infection with a virus. As a result, vaccinated people can contract a Covid-19 infection confined to the mucous membranes. They may get the sniffles but can spread the virus to others even if they are asymptomatic. That’s why it makes sense for them to wear a mask under some circumstances.

All this has implications for public-health authorities’ determination to achieve herd immunity through vaccination alone. In the Provincetown, Mass., outbreak, which informed the CDC’s recent change in guidelines, viral loads in the nose were “similarly high” in the vaccinated and unvaccinated, suggesting that the vaccine’s efficacy against infection in the nose had fallen to zero with the advent of the Delta variant. That would mean herd immunity through vaccination is impossible.

But this data appears to be distorted by ascertainment bias: The vaccinated people who showed up for testing were disproportionately those who were symptomatic. Better-controlled data from the Mayo Clinic suggests that efficacy of the vaccines against nasal infection, including asymptomatic cases, has fallen from the original level of around 90% to 76% for the Moderna vaccine and 42% for the Pfizer vaccine since Delta’s emergence. It follows that herd immunity from intramuscular vaccination is still possible, but it would require either a higher level of vaccination or continued masking and social distancing.

Vaccines administered via nasal spray exist for other ailments, including polio. They’re under development for Covid-19 to supplement existing shots with mucosal immunity. In the meantime, herd immunity may prove difficult to achieve unless more people get infected and develop natural immunity of both types. Given the dangers of infection, officials are rightly reluctant to encourage actual infection, and loath to mention its benefit in conferring mucosal immunity.

But we shouldn’t shun people who have recovered from Covid. Vaccine mandates for in-person interactions—whether imposed by governments, employers or businesses—should make exceptions for the previously infected, who thanks to natural mucosal immunity are likely at less risk than never- infected vaccinated people of spreading the virus to others.

Dr. Segal is a neurologist and neuroscientist

Content last modified on August 30, 2021, at 10:00 PM EST